S&P 500 7718.60 -0.38%
NASDAQ 26506.99 -0.29%
TASI 11024.73 -0.40%
Oil (WTI) 91.48 +0.00%
Oil (Brent) 96.28 +0.00%
VIX 15.26 +5.02%
Gold 4476.60 +0.00%
USD/SAR 3.76 +0.02%

Becton, Dickinson and Company

BDX · Healthcare · · USD
184.74 USD
0.00 (-1.54%)
● Updated 2026-09-07 18:34 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

77
/ 100
Technical 75
Trend & RS 95
Momentum 76
Fundamental 67
Macro 64
Liquidity 46
ComponentScoreWeight
Technical 75.0 20%
Trend & RS 95.2 30%
Momentum 76.1 15%
Fundamental 66.7 10%
Macro 64.4 20%
Liquidity 45.7 5%

Trade Setup

Entry 184.74
Stop Loss 176.48 (4.5%)
Target 1 (1:1) 193.00 (+4.5%)
Target 2 (2:1) 201.26 (+8.9%)
ATR(14) 4.13 (2.2%)
Risk per Share 8.26
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 61.8 +0.47
Momentum 76.1 +1.04
Quality 24.0 -1.04
Composite 54.0

Quality Scores

Piotroski F-Score 6 /9 — Average
✓ ✓ ✗ ✗ ✓ ✗ ✓ ✓ ✓
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score Insufficient Data

Valuation vs Peers Fair Value

MetricStockSectorvs Peers
P/E Ratio 32.0 22.0 +45% above
P/B Ratio 2.1 4.0 Below
Dividend Yield 2.3% 1.5% Above avg

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value
82.57
vs
Market Price
184.74
Upside
-55.3%
Margin of Safety -123.7%
Stage 1 PV (5yr FCF)5,700,408,806
Terminal Value PV16,791,325,550
Total Enterprise Value22,491,734,356

Assumptions

Base FCF1,259,516,636
Growth Rate (5yr)5.4%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
49.71%
Full Kelly
24.86%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 77/100. Estimated win rate 63%, avg win 9.6%, avg loss 3.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

3
Bullish Signals
1
Bearish Signals
57.51
RSI(14)
5.0077
MACD

Relative Strength (RS) IMPROVING

87
/ 99
RS Rating
✓ O'Neil PASS (≥80)
RS vs SPY ↑ RISING (+18.4% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High No (10d since high)
Sector Outperformance +15.3% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

IndicatorValueSignal
Rsi 57.51 NEUTRAL
Macd 5.0077 BEARISH
Ma Cross 170.0 / 158.61 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 0.88x NORMAL

Key Levels

LevelPrice
52-Week High193.07
Bollinger Upper193.54
SMA(200)158.61
SMA(50)170.0
SMA(20)186.18
Current Price184.74
Bollinger Lower178.82
52-Week Low127.59
ATR(14)4.13

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence
100%
Acc: 0.0  |  Dist: 0.0  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-08-31 Normal 1.61x Normal bar — no special VSA pattern
2026-09-01 Normal 0.79x Normal bar — no special VSA pattern
2026-09-02 Normal 0.91x Normal bar — no special VSA pattern
2026-09-03 Normal 0.74x Normal bar — no special VSA pattern
2026-09-04 Normal 0.88x Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 187.91 Above Kijun
Kijun-sen (26) 177.76 Base line
Senkou A 182.83 Leading span A
Senkou B 168.84 Leading span B
Cloud 168.84 – 182.83 Bullish (Green)
Price vs Cloud 184.74 Above Cloud
Chikou Span 165.62 Bullish
Alignment Score 4/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BULLISH FADING
BB: 178.82 – 193.54  |  KC: 180.1 – 192.25

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bearish MACD 11

Anchored VWAP

VWAP: 156.73 Anchor: 2025-11-06 (52w Low) ABOVE AVWAP +17.9%

Heikin-Ashi Trend

EXHAUSTION Trend exhaustion (3 doji candles) Full data via /api/advanced/BDX

Valuation

MetricValue
Market Cap50.32B
P/E (TTM)31.96
Forward P/EN/A
P/B2.06
EPS5.78

Financial Health

MetricValue
Revenue Growth5.4%
Profit Margin4.2%
ROE6.6%
Debt/Equity68.84
Current Ratio0.86
Dividend Yield2.3%
Payout RatioN/A
Beta0.28

Trading Data

184.74
Open
184.74
Day High
184.74
Day Low
1.44M
Volume (0.7x avg)

Recent News (8)

How Much Upside Can BSX Stock's Growth Deliver?
Trefis · 2026-09-04
How Is Becton, Dickinson and Company's Stock Performance Compared to Other Medical Devices Stocks?
Barchart · 2026-09-04
3 Dividend Stocks From a Value Pro
Barrons.com · 2026-09-04
Becton Dickinson (BDX) Becomes Founding Sponsor Of Hazardous Drug Data Consortium
Simply Wall St. · 2026-09-03
The Wide Divide Priced Into Boston Scientific Stock
Trefis · 2026-09-02
Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat
MT Newswires · 2026-09-01
The Peer-Group Mispricing Sitting On BSX Stock
Trefis · 2026-09-01
Two Recessions Couldn’t Stop These 4 Healthcare Stocks From Raising Dividends
24/7 Wall St. · 2026-08-31

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —